The FDA adds a new boxed warning for immune effector cell-associated enterocolitis with Carvykti, but says the overall ...

A mother-of-one battling stage four blood cancer has shunned chemotherapy in favour of a controversial 'water-fasting', after ...

Learn the signs, symptoms, risk factors, and treatments for Hodgkin lymphoma—plus insights from a doctor who’s also a ...

Recent noteworthy reports on diffuse large B-cell lymphoma (DLBCL) include positive survival results with an antibody-drug conjugate in relapsed/refractory disease, FDA issues with a randomized trial, ...

Introduction: The exhaustion of chimeric antigen receptor T cells (CAR-T) hampers the efficacy of CAR-T cell therapy. Persistent antigen stimulation in T cells results in a surge of intracellular ...

To confirm a diagnosis and determine the stage of the disease, your doctor will use a series of tests: Biopsy: This is the most definitive test. A surgeon will remove all or part of an affected lymph ...

Being diagnosed with a serious disease like Hodgkin lymphoma is a lot to digest. But once you’ve had time to process your diagnosis, talk will likely turn to the treatments for classic Hodgkin ...

New research challenges the status quo that cancer treatments are responsible for accelerating the aging process, indicating that cancer itself also plays a role. A team of researchers from Moffitt ...

New York, NY (August 21, 2025) – A team of researchers from The Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai has successfully treated a rare and aggressive T-cell lymphoma ...

To the Editor: Svoboda et al. (May 8 issue) 1 report on a study of an enhanced chimeric antigen receptor (CAR) T-cell product (huCART19-IL18) in patients with relapsed or refractory lymphoma after ...